Market revenue in 2022 | USD 13.8 million |
Market revenue in 2030 | USD 25.8 million |
Growth rate | 8.1% (CAGR from 2022 to 2030) |
Largest segment | Product |
Fastest growing segment | Services |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Services, Product |
Key market players worldwide | Abcam PLC, Sino Biological, Bio-Techne Corp, Genscript Biotech Corp Class H, Bio-Rad Laboratories Inc, Merck KGaA, Thermo Fisher Scientific Inc, Proteintech Group, Enzo Biochem Inc, Abnova, RayBiotech, STEMCELL Technologies |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to recombinant proteins market will help companies and investors design strategic landscapes.
Product was the largest segment with a revenue share of 68.12% in 2022. Horizon Databook has segmented the South Africa recombinant proteins market based on services, product covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa recombinant proteins market , including forecasts for subscribers. This country databook contains high-level insights into South Africa recombinant proteins market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account